HomeInsightsPE

Novartis India Ltd PE Ratio

Novartis India Ltd PE Ratio

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Nov 25, 2024)

stocks purchased

2.6 K

Stocks Traded

(Nov 25, 2024)

Last Updated on: Nov 26, 2024

Image

Novartis India Ltd

NSE: NOVARTIND

PE

29

Last updated on: Nov 26, 2024

Key Highlights

  • The P/E Ratio of Novartis India Ltd is 29 as of 26 Nov 9.00 AM .
  • The P/E Ratio of Novartis India Ltd changed from 32.7 on March 2019 to 29.8 on March 2024 . This represents a CAGR of -1.54% over 6 years.
  • The Latest Trading Price of Novartis India Ltd is ₹ 1027 as of 25 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Novartis India Ltd

No data available

Company Fundamentals for Novartis India Ltd

No data available

Image

Novartis India Ltd

NSE: NOVARTIND

Share Price

₹ 1027.8

2.00 (0.19%)

stock direction

Last updated on: Nov 25, 2024

Market Price of Novartis India Ltd

1M

1Y

3Y

5Y

Monitoring Novartis India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
25 Nov 20241027.8
22 Nov 20241025.8
21 Nov 20241024.35
19 Nov 20241022.9
18 Nov 20241034.9
14 Nov 20241061.4
13 Nov 20241054.95
12 Nov 20241072.8
11 Nov 20241049.35
08 Nov 20241079.45

SWOT Analysis Of Novartis India Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Novartis India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Novartis India Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Novartis India Ltd292,537
Sun Pharmaceuticals Industries Ltd384,32,996
Divis Laboratories Ltd881,63,016
Cipla Ltd261,21,414
Torrent Pharmaceuticals Ltd631,10,599
Mankind Pharma Ltd491,04,655

Key Valuation Metric of Novartis India Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Novartis India Ltd

No data available

* All values are in crore

Historical Revenue of Novartis India Ltd

No data available

* All values are in crore

Historical EBITDA of Novartis India Ltd

No data available

* All values are in crore

Historical Net Profit of Novartis India Ltd

No data available

* All values are in crore

Historical Dividend Payout of Novartis India Ltd

No data available

* All values are in %

About Novartis India Ltd

  • Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947.
  • The Company is focused on manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates in four segments such as Pharmaceuticals, Generics, Over the Trade Counter and Animal Health. The origin of Novartis is linked to the origin of three distinct companies namely Geigy, Ciba, and Sandoz.
  • The history of Geigy goes back to the middle of the 18th century, Ciba was founded around 1860, and Sandoz was set-up in 1886.
  • In 1970 Ciba and Geigy merged to form Ciba-Geigy Ltd. Sandoz and Ciba-Geigy Ltd continued as separate entities for the next 25 years.
  • In 1996, in one of the largest corporate mergers in history Sandoz and Ciba-Geigy Ltd.

Novartis India Ltd News Hub

News

Novartis India schedules board meeting

Novartis India will hold a meeting of the Board of Directors of the Company on 25 October ...

Read more

2024-09-28 00:00:00

News

Novartis India standalone net profit declines 13.81% in the September 2024 quarter

Net profit of Novartis India declined 13.81% to Rs 20.41 crore in the quarter ended Septem...

Read more

2024-10-25 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Novartis India Ltd

What is the current PE Ratio of Novartis India Ltd?

The Current PE Ratio of Novartis India Ltd is 29.03 as on 26 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 26 Nov 2024.

What was the PE Ratio of Novartis India Ltd last year?

The PE Ratio of Novartis India Ltd was 13.5 last year, now the PE ratio is 29.03, showing a year-on-year growth of 115.0%.

What does the PE Ratio of Novartis India Ltd indicate about its stock?

The PE Ratio of Novartis India Ltd is 29.03. This ratio indicates that investors are willing to pay 29.03 times the earnings per share for each share of Novartis India Ltd.

What is the PE Ratio Growth of Novartis India Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Novartis India Ltd grew by 115.0% whereas, the EPS ratio grew by -20.6.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*